These lab-built alternate options weren't designed with recreational use in mind. From the nineteen nineties, John W. Huffman along with a group of fellow chemists at Clemson University developed many of the first formulation for synthetic cannabinoid receptor agonists (SCRAs), a family of substances that imitate the physiological and psychological